当前位置： SCI文献检索 > RADIOLOGY期刊下所有文献 > Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.

Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.

Abstract：

PURPOSE:To retrospectively compare sensitivity and specificity of magnetic resonance (MR) imaging, three-dimensional (3D) MR spectroscopy, combined MR imaging and 3D MR spectroscopy, and carbon 11 (11C)-choline positron emission tomography (PET)/computed tomography (CT) for intraprostatic tumor sextant localization, with histologic findings as reference standard. MATERIALS AND METHODS:The local ethics committee on human research provided approval and a waiver of informed consent for the retrospective study. MR imaging, 3D MR spectroscopy, and 11C-choline PET/CT results were retrospectively reviewed in 26 men with biopsy-proved prostate cancer (mean age, 64 years; range, 51-75 years) who underwent radical prostatectomy. Cancer was identified as areas of nodular low signal intensity on T2-weighted MR images. At 3D MR spectroscopy, choline-plus-creatine-to-citrate and choline-to-creatine ratios were used to distinguish healthy from malignant voxels. At PET/CT, focal uptake was visually assessed, and maximum standardized uptake values (SUVs) were recorded. Agreement between 3D MR spectroscopic and PET/CT results was calculated, and ability of maximum SUV to help localize cancer was assessed with receiver operating characteristic analysis. Significant differences between positive and negative sextants with respect to mean maximum SUV were calculated with a paired t test. RESULTS:Sensitivity, specificity, and accuracy were, respectively, 55%, 86%, and 67% at PET/CT; 54%, 75%, and 61% at MR imaging; and 81%, 67%, and 76% at 3D MR spectroscopy. The highest sensitivity was obtained when either 3D MR spectroscopic or MR imaging results were positive (88%) at the expense of specificity (53%), while the highest specificity was obtained when results with both techniques were positive (90%) at the expense of sensitivity (48%). Concordance between 3D MR spectroscopic and PET/CT findings was slight (kappa=0.139). CONCLUSION:In localizing cancer within the prostate, comparable specificity was obtained with either 3D MR spectroscopy and MR imaging or PET/CT; however, PET/CT had lower sensitivity relative to 3D MR spectroscopy alone or combined with MR imaging.

journal_name

Radiology

journal_title

Radiology

authors

Testa C,Schiavina R,Lodi R,Salizzoni E,Corti B,Farsad M,Kurhanewicz J,Manferrari F,Brunocilla E,Tonon C,Monetti N,Castellucci P,Fanti S,Coe M,Grigioni WF,Martorana G,Canini R,Barbiroli B

doi

10.1148/radiol.2443061063

subject

Has Abstract

pub_date

2007-09-01 00:00:00

pages

797-806

issue

eissn

0033-8419

issn

1527-1315

pii

2443061063

journal_volume

244

pub_type

杂志文章

在线工具

Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.